Introduction To what degree population-level antibiotic use contributes to Neisseria gonorrhoeae (NG) resistance in the US is unclear. We investigated whether outpatient prescribing is associated with NG antibiotic susceptibility. Methods Using data from the Gonococcal Isolate Surveillance Project (GISP; a US surveillance system that samples male urethral isolates) during 2005-2013, we calculated annual geometric mean minimum inhibitory concentrations (MICs) of azithromycin, cefixime, and ceftriaxone by site. We used QuintilesIMS data (captures>70% of US outpatient prescriptions and projects to 100% coverage) to calculate annual cephalosporin and macrolide rates prescribing per 1000 men by each county corresponding to a GISP site. For descriptive analyses, we calculated site-specific medians of these measures. We constructed multivariable linear mixed models for each agent with annual prescribing rates as the exposure and one-year lagged geometric mean MIC as the outcome. Results Annual geometric mean cefixime MICs increased from 0.009 mg/ml (2005) to 0.021 (2013), ceftriaxone from 0.005 (2006) to 0.01 (2007-2013) , and azithromycin from 0.171 (2011) to 0.242 (2008 (66%) is under 50 years old and a considerable number (32%) of individuals survived until two years after the diagnosis. Late-diagnosis, late implementation of TARV and poor adhesion are notable among the deaths, as well as a significant ratio (29%) of substance-abusing individuals. AIDS-defining illnesses (particularly tuberculosis) rank as the highest causes of death (55%) followed by non-AIDSdefining bacterial infections (18%), which are both predominant among the deaths of those patients with therapeutic disruption and/or advanced HIV infection. Causes unrelated to HIV and bacterial infections are predominant among patients with suppression of HIV-replication and recent CD4 count above 500 cells/mm 3 . Conclusion Even in light of a positive context due to the decrease of MR, the oversight of deaths of HIV-infected individuals remains a fundamental practice for identifying vulnerabilities and works as a guiding principle for interventions that may contribute to a decrease in the number of avoidabledeaths. The results indicate the relevance of actions towards early-diagnosing, monitoring of patient-enrollment and adhesion to services, timely start of antiretroviral therapy, continued oversight of patient-adhesion to medications and diagnosis as well as towards the treatment of potentially-avoidable conditions such as latent infection of tuberculosis and vaccination for pneumococo. Some groups -such as drug and alcoholabusing individuals -require a case-by-case approach. compare these rates to those observed in pregnant women outside of jail; and to verify the maternal factors associated with syphilis infection during pregnancy in free and incarcerated women. Methods We used data from two nationwide studies conducted during the period 2011-2014. The "Birth in Brazil" study included 23 894 free women cared for in 266 hospitals. The "Maternal and Infant Health in Prisons" study included 495 incarcerated pregnant women or mothers living with their children, according to a census conducted in 33 female prisons. The same case definitions and data collection methods were used in both studies. We used the Chi square test to compare the characteristics of incarcerated and free women with a significance of 0.05. Results For incarcerated women, the estimated prevalence of syphilis during pregnancy was 8.7% (IC 95% 5.7-13.1) and for HIV infection 3.3% (IC 95% 1.7-6.6), rates almost 7 times greater than that found in free women. The estimated MTCT of syphilis was 66.7% (IC 95% 44.7-83.2) and the incidence of congenital syphilis at birth was 58.1 per 1000 living newborns (IC 95% 40.4-82.8), rates two and 12.6 times higher than in free women, respectively. Incarcerated women showed greater social vulnerability and worse results in all the evaluated antenatal indicators. Syphilis infection was associated with social vulnerability in free women, but not in incarcerated women. Conclusion Incarcerated women had a higher prevalence of syphilis and HIV infection during pregnancy, lower quality of antenatal care and higher levels of social vulnerability. Health initiatives in the prison system are necessary to reduce healthcare inequalities and should include adequate antenatal and birth care with opportune diagnosis and treatment of infected pregnant women as recommended in national and international guidelines. Introduction HIV and herpes simplex virus type 2 (HSV-2) infections are sexually transmitted and propagate in sexual networks. Our study's objectives were to quantify effects of key network statistics on infection transmission, and extent to which HSV-2 prevalence is predictive of HIV prevalence. Methods An individual-based Monte Carlo simulation model was constructed to describe sex partnering and infections transmission. The model was parametrized with current and representative natural history, transmission, and sexual behaviour data. Correlations were assessed on model outcomes and multiple linear regressions were conducted to estimate adjusted associations and effect sizes. Results HIV prevalence was most often lower than a third of HSV-2 prevalence. HIV and HSV-2 prevalences were associated with a Spearman's rank correlation coefficient of 0.64 (95% CI: 0.58-0.69). Collinearities among network statistics were detected, most notably between concurrency versus mean and variance of number of partners. Controlling for confounding, unmarried mean number of partners (or alternatively concurrency) were the strongest predictors of HIV prevalence. Meanwhile, unmarried and married mean and variance of number of partners (or alternatively concurrency), and clustering coefficient were the strongest predictors of HSV-2 prevalence. HSV-2 prevalence was a strong predictor of HIV prevalence by proxying effects of network statistics. Conclusion Network statistics drive similar and differential effects on HIV and HSV-2 transmission. HIV prevalence reflected primarily mean and variance of number of partners, but HSV-2 prevalence was affected by a range of network statistics. HSV-2 prevalence can be used to predict a population's HIV epidemic potential, thereby informing HIV prevention interventions. Introduction With anti-retroviral therapy (ART) for human immunodeficiency virus infection (HIV) coming into picture, quality of life (QOL) has gained importance. Knowledge on the factors affecting QOL would be helpful in making important policy decisions and health care interventions. The aim of this study is to assess the quality of life of people living with HIV (PLWH) and to identify the factors influencing their QOL. Methods The study was done among 100 PLWH attending a tertiary care hospital, and three Non-Governmental Organisations at Calicut, Kerala, India, from June 2011 to May 2014. QOL was assessed using HIV specific World Health Organisation Quality Of Life scale (WHOQOL-HIV) -BREF questionnaire which has six domains (physical, psychological, level of independence, social relationships, environment and spirituality/religiousness/personal belief). Social support and stigma were measured using "Multidimensional Scale of Perceived Social Support" and "HIV Stigma Scale," respectively, using Likert Scale. Factors influencing QOL were identified using backward stepwise multiple linear regression with the six domain scores as the dependent variables. Results Male: Female ratio was 1:1% and 58% were in early stage of the disease (stage I/II). Psychological and SRPB (Spirituality Religiousness and Personal Beliefs) domains were the most affected domains. All the regression models were statistically significant (p<0.05). The determination coefficient was highest for the social relationship domain (57%) followed by the psychological domain (51%). Disease stage and perceived social support significantly influenced all the domains of WHOQOL. Younger age, female gender, rural background, shorter duration of HIV, non-intake of ART and greater HIV related stigma were the high risk factors of poor QOL. Conclusion Interventions such as ART, family, vocational and peer counselling would address these modifiable factors influencing QOL, thereby improving the QOL of PLWH. Introduction Depression is accounted as one of the major contributors towards the neuropsychiatric complication among person living with HIV. Depression leads to the non-compliance and accounted for the worst outcomes. So, this study was aimed to assess the prevalence and correlates of depression. Methods This was a cross-sectional study conducted at the Anti-retroviral therapy (ART) centre, RMRIMS, Patna, India. The study protocol was approved by the institutional ethics committee of Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna (04/RMRI/EC/2016). Patients were interviewed with the Patient Health Questionnaire (PHQ-9) to assess the prevalence of depression. Association of depression with respect to demographic and disease-related factors were also assessed. Data were coded and analysed using SPSS v22. Results A total of 144 patients suffering from HIV were participated in this study. Among this selected participants, 47% were female. The mean age of participants was 38.8 years (SD=11.4). Depression was prevalent in 57% (95% CI: 48.91 to 65.09) of patient participated in the study and was highly prevalent in female (66%). Prevalence of depression was higher in patient belongs to upper lower and lower socioeconomic class. More than a quarter 28% (95% CI: 21.56 to 36.44) of respondents had mild depression, while 29% (95% CI: 21.99 to 36.41) of participants were suffering from moderate to severe depression. Prevalence of depression was found to be significantly associated with lower socioeconomic class (OR 2.458, 95% CI 1.081-5.592; p<0.05). Conclusion Depression is highly prevalent among HIV-positive patients in Bihar region. Higher odds of prevalent depression were observed in lower socioeconomic class. Nearly 30% HIV positive patients were suffering from moderate to severe depression.
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